Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment.
Saved in:
| Title: | Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment. |
|---|---|
| Authors: | Deutsch BC; Department of Otolaryngology-Head & Neck Surgery, Washington University School of Medicine, St Louis, Missouri., Collopy C; Division of Adult Audiology, Department of Otolaryngology-Head & Neck Surgery, Washington University School of Medicine, St Louis, Missouri., Kallogjeri D; Department of Otolaryngology-Head & Neck Surgery, Washington University School of Medicine, St Louis, Missouri., Piccirillo JF; Department of Otolaryngology-Head & Neck Surgery, Washington University School of Medicine, St Louis, Missouri. |
| Source: | JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2021 Feb 01; Vol. 147 (2), pp. 182-189. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Validation Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589542 Publication Model: Print Cited Medium: Internet ISSN: 2168-619X (Electronic) Linking ISSN: 21686181 NLM ISO Abbreviation: JAMA Otolaryngol Head Neck Surg Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-619X |
|---|---|
| DOI: | 10.1001/jamaoto.2020.4620 |
